Update of A Public Health Action Plan To Combat Antimicrobial Resistance, 58096 [E7-20125]
Download as PDF
<![CDATA[
58096
Federal Register / Vol. 72, No. 197 / Friday, October 12, 2007 / Notices
jlentini on PROD1PC65 with NOTICES
formulation and execution; provides
liaison on personnel management
activities with the OPHS, and the
Program Support Center; and is
responsible for implementing the
Congressional, international health,
national (regional) components for the
OWH mission. The Office will also
provide scientific analyses for all
initiatives.
2. Division of Program Coordination
(ACB2). The Division of Program
Coordination (DPC), headed by the
Division Director, advises the OWH
Director on the development of strategic
and operational plans and provides staff
support to and liaison with program
staff in coordinating, integrating, and
articulating these plans; advises the
OWH Director on policy issues;
develops plans for evaluating the focus
and impact of ongoing programs and the
development of new programs and
policies; and provides analytical reports
of program trends and future forecasts.
3. Division of Outreach and
Collaboration (ACB3). The Division of
Outreach and Collaboration (DOB),
headed by the Division Director,
provides oversight and direction to the
OWH’s communication programs
consistent with policy direction
established by the Office of the
Assistant Secretary for Public Affairs;
systematically captures, assesses, and
disseminates information on scientific
and policy developments relating to
women’s health research results and
current or emerging trends and issues;
manages the OWH information,
education and awareness activities both
within the Department and externally;
coordinates, assigns, develops,
researches, and prepares briefing
materials on women’s health for OWH
Director and other HHS offices; manages
public information activities and media
and press relations; plans and
coordinates efforts to promote the
OWH’s programs and policies in the
voluntary and corporate sectors;
manages exhibits; and develops visual
and other graphic materials for the
OWH.
II. Under Chapter AC, Office of Public
Health and Science, Section AC.20
Functions, at the end of Paragraph A,
‘‘Immediate Office (ACA),’’ add the
following statement:
(19) Provide administrative and
management support to the President’s
Council on Bioethics.
Dated: October 1, 2007.
Joe W. Ellis,
Assistant Secretary for Administration and
Management.
[FR Doc. 07–5046 Filed 10–11–07; 8:45 am]
BILLING CODE 4150–33–M
VerDate Aug<31>2005
16:35 Oct 11, 2007
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Update of A Public Health Action Plan
To Combat Antimicrobial Resistance
The Centers for Disease Control and
Prevention (CDC), Food and Drug
Administration (FDA), and National
Institutes of Health (NIH) announce an
open meeting concerning antimicrobial
resistance.
Name: Update of A Public Health
Action Plan To Combat Antimicrobial
Resistance.
Times and Dates: 8:30 a.m.–6 p.m.,
December 12, 2007; 8 a.m.–3 p.m.,
December 13, 2007.
Place: Grand Hyatt Atlanta in
Buckhead, 3300 Peachtree Road,
Atlanta, Georgia, USA 30305. Tel: +1
404/237–1234, Fax: +1 404/233–5686.
Status: Open to the public, limited
only by the space available.
Purpose: To solicit input from invited
consultants to update A Public Health
Action Plan To Combat Antimicrobial
Resistance that, when published in
2001, provided a blueprint for activities
of Federal agencies to combat
antimicrobial resistance. The Plan was
developed by consultants from multidisciplines and the Antimicrobial
Resistance Task Force, composed of
Federal personnel from ten Federal
agencies and departments, co-chaired by
CDC, FDA, and NIH. The revised Plan
will not be limited to domestic
activities.
Matters To Be Discussed: The agenda
will focus on updates and revisions of
existing action items or the addition of
new items to the Plan. Action items in
A Public Health Action Plan To Combat
Antimicrobial Resistance are presented
in four major topics:
1. Surveillance.
2. Prevention and Control.
3. Research.
4. Product Development.
Comments and suggestions from the
consultants for updates of specific
action items in the Action Plan or
addition of new action items in these
topics will be taken under advisement
by the Task Force. The Task Force may
also utilize other sources of information
in updating the Action Plan. The agenda
does not include development of
consensus positions, guidelines, or
discussions or endorsements of specific
commercial products. Agenda items are
subject to change as priorities dictate.
Limited time will be available for oral
comments and suggestions from the
public. Written comments and
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
suggestions from the public are
encouraged and should be received by
the contact person listed below by
December 3, 2007.
Persons anticipating attending the
meeting are requested to send written
notification by December 3, 2007,
including name, organization (if
applicable), address, phone, fax, and
email addresses to the contact below.
For Further Information Contact:
Gregory J. Anderson, Centers for Disease
Control and Prevention (CDC), Office of
Antimicrobial Resistance, Mailstop A–
07, 1600 Clifton Road, NE., Atlanta,
Georgia 30333. Telephone +1 404/639–
3539, fax +1 404/639–7444, e-mail:
gca5@cdc.gov.
Dated: October 4, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E7–20125 Filed 10–11–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10185, CMS–
10137, CMS–10240, CMS–10237 and 10214,
CMS–855, and CMS–R–39]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare Part D
AGENCY:
E:\FR\FM\12OCN1.SGM
12OCN1
]]>Agencies
[Federal Register Volume 72, Number 197 (Friday, October 12, 2007)]
[Notices]
[Page 58096]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-20125]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Update of A Public Health Action Plan To Combat Antimicrobial
Resistance
The Centers for Disease Control and Prevention (CDC), Food and Drug
Administration (FDA), and National Institutes of Health (NIH) announce
an open meeting concerning antimicrobial resistance.
Name: Update of A Public Health Action Plan To Combat Antimicrobial
Resistance.
Times and Dates: 8:30 a.m.-6 p.m., December 12, 2007; 8 a.m.-3
p.m., December 13, 2007.
Place: Grand Hyatt Atlanta in Buckhead, 3300 Peachtree Road,
Atlanta, Georgia, USA 30305. Tel: +1 404/237-1234, Fax: +1 404/233-
5686.
Status: Open to the public, limited only by the space available.
Purpose: To solicit input from invited consultants to update A
Public Health Action Plan To Combat Antimicrobial Resistance that, when
published in 2001, provided a blueprint for activities of Federal
agencies to combat antimicrobial resistance. The Plan was developed by
consultants from multi-disciplines and the Antimicrobial Resistance
Task Force, composed of Federal personnel from ten Federal agencies and
departments, co-chaired by CDC, FDA, and NIH. The revised Plan will not
be limited to domestic activities.
Matters To Be Discussed: The agenda will focus on updates and
revisions of existing action items or the addition of new items to the
Plan. Action items in A Public Health Action Plan To Combat
Antimicrobial Resistance are presented in four major topics:
1. Surveillance.
2. Prevention and Control.
3. Research.
4. Product Development.
Comments and suggestions from the consultants for updates of
specific action items in the Action Plan or addition of new action
items in these topics will be taken under advisement by the Task Force.
The Task Force may also utilize other sources of information in
updating the Action Plan. The agenda does not include development of
consensus positions, guidelines, or discussions or endorsements of
specific commercial products. Agenda items are subject to change as
priorities dictate. Limited time will be available for oral comments
and suggestions from the public. Written comments and suggestions from
the public are encouraged and should be received by the contact person
listed below by December 3, 2007.
Persons anticipating attending the meeting are requested to send
written notification by December 3, 2007, including name, organization
(if applicable), address, phone, fax, and email addresses to the
contact below.
For Further Information Contact: Gregory J. Anderson, Centers for
Disease Control and Prevention (CDC), Office of Antimicrobial
Resistance, Mailstop A-07, 1600 Clifton Road, NE., Atlanta, Georgia
30333. Telephone +1 404/639-3539, fax +1 404/639-7444, e-mail:
gca5@cdc.gov.
Dated: October 4, 2007.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E7-20125 Filed 10-11-07; 8:45 am]
BILLING CODE 4163-18-P
